NASDAQ·US·Drug Manufacturers - General

ABBVABBV

สรุป

เสี่ยง

ความมั่นใจ 89%
$203.89—

Today's session

Upside?
+50.0%
FV $351.58
P/E (TTM)?
99.9
Earnings yield
FCF yield?
5.1%
Mcap $360.63B

ถือ

Fundamental neutral·Technical sell

What investors notice

Key signs

Plain-language read of the metrics that matter most for this stock.

Strongly positive
9 · 1 · 2

Strengths

9
  • Best-in-class return on equity81%
  • High return on invested capital20%
  • Gross margin trending up
  • Recent growth re-accelerating
  • Pristine fundamentals (Piotroski 7+)9/9
  • Trading well below consensus fair value50%
  • High FCF yield5%
  • ROIC well above cost of capital — value-creating20%
  • Analyst consensus heavily Buy-skewed

Risks

2
  • Inconsistent profitability4/10
  • EPS shrinking on a 5-year basis-29%

Watchlist

1
  • Long-term debt rising — monitor leverage
$203.89+8.8%

1Y · period change vs 2025-04-29

Score history (10y)

How quality has trended through cycles.

+2 YoY

Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.

Fair value range

4 of 5 models · trimmed-mean consensus

Consensus FV
$351.58
Upside
+50.0%
Now $203.89
Our FV$351.58
Price$203.89
$31.86$614.33

Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.

10-year financials

Annual revenue, profit, and free cash flow with year-over-year growth overlay.

YoY growth overlaid

Snapshot

At a glance

Top-line figures most investors check first.

Market cap
$360.63B
P/E (TTM)?
99.9
FCF yield?
5.1%
Dividend
—
52w range
$171.84 – $238.71
Score confidence
89%
Data completeness

Last updated 4/30/2026, 5:21:11 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer